180 Life Sciences is developing new treatments for one of the world's biggest drivers of disease: inflammation.
The company consists of three programs developing novel drugs for treating distinct inflammatory diseases. These programs are led by world-leading scientists at prestigious universities who have already developed blockbuster drugs and made ground-breaking discoveries in their fields. One of the programs is conductin...
180 Life Sciences is developing new treatments for one of the world's biggest drivers of disease: inflammation.
The company consists of three programs developing novel drugs for treating distinct inflammatory diseases. These programs are led by world-leading scientists at prestigious universities who have already developed blockbuster drugs and made ground-breaking discoveries in their fields. One of the programs is conducting a phase 2b/3 trial and expects its first results in Q4 2021. Other clinical trials are expected to begin by the end of 2021.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.